Search research articles
Contact Us
Filters
Showing results (11-20 of 73) with videos related to
Page
of 8
Sort By:
Frontiers in Psychiatry
|
March 11, 2020
Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
David R Goldsmith, Mark Hyman Rapaport
Focus (American Psychiatric Publishing)
|
September 6, 2021
Tardive Dyskinesia: Spotlight on Current Approaches to Treatment
Sarah M Debrey, David R Goldsmith
Drugs
|
March 18, 2004
Inhaled iloprost: in primary pulmonary hypertension
David R Goldsmith, Antona J Wagstaff
American Journal of Clinical Dermatology
|
April 1, 2005
Etanercept: a review of its use in the management of plaque psoriasis and psoriatic arthritis
David R Goldsmith, Antona J Wagstaff
Drugs
|
September 16, 2005
Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia
David R Goldsmith, Greg L Plosker
Focus (American Psychiatric Publishing)
|
December 21, 2020
Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder
Brian J Miller, David R Goldsmith
Drugs
|
March 11, 2006
Mammalian cell-derived somatropin : a review of its use in the management of HIV-associated wasting
David R Goldsmith, Antona J Wagstaff
The Primary Care Companion for CNS Disorders
|
August 11, 2017
An Unmet Need: A Clozapine-Induced Myocarditis Screening Protocol
David R Goldsmith, Robert O Cotes
Drugs
|
July 6, 2004
Budesonide/formoterol: a review of its use in asthma
David R Goldsmith, Gillian M Keating
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
January 6, 2006
Spotlight on etanercept in plaque psoriasis and psoriatic arthritis
David R Goldsmith, Antona J Wagstaff
Page
of 8
Search research articles
Search
Showing results (11-20 of 73) with videos related to
Sort By:
Page
of 8
Frontiers in Psychiatry
|
March 11, 2020
Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
David R Goldsmith, Mark Hyman Rapaport
Focus (American Psychiatric Publishing)
|
September 6, 2021
Tardive Dyskinesia: Spotlight on Current Approaches to Treatment
Sarah M Debrey, David R Goldsmith
Drugs
|
March 18, 2004
Inhaled iloprost: in primary pulmonary hypertension
David R Goldsmith, Antona J Wagstaff
American Journal of Clinical Dermatology
|
April 1, 2005
Etanercept: a review of its use in the management of plaque psoriasis and psoriatic arthritis
David R Goldsmith, Antona J Wagstaff
Drugs
|
September 16, 2005
Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia
David R Goldsmith, Greg L Plosker
Focus (American Psychiatric Publishing)
|
December 21, 2020
Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder
Brian J Miller, David R Goldsmith
Drugs
|
March 11, 2006
Mammalian cell-derived somatropin : a review of its use in the management of HIV-associated wasting
David R Goldsmith, Antona J Wagstaff
The Primary Care Companion for CNS Disorders
|
August 11, 2017
An Unmet Need: A Clozapine-Induced Myocarditis Screening Protocol
David R Goldsmith, Robert O Cotes
Drugs
|
July 6, 2004
Budesonide/formoterol: a review of its use in asthma
David R Goldsmith, Gillian M Keating
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
January 6, 2006
Spotlight on etanercept in plaque psoriasis and psoriatic arthritis
David R Goldsmith, Antona J Wagstaff
Page
of 8